Adapt Produtos Oftalmológicos Ltda.

Quick facts

Phase 3 pipeline

• moxifloxacin 0,5% + prednisolone 1% · Ophthalmology
  Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other pro-inflammatory enzymes.
• moxifloxacin/prednisolone combination · Ophthalmology
  Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while prednisolone is a corticosteroid that reduces inflammation by inhibiting phospholipase A2 and other enzymes.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Adapt Produtos Oftalmológicos Ltda. portfolio CI brief
• Adapt Produtos Oftalmológicos Ltda. pipeline updates RSS